Patent foramen ovale (PFO) is a risk factor for cryptogenetic stroke; its closure should be considered in selected patients. It is not always clear whether symptoms (presyncope, paresthesia) apparently due to paradoxical embolism are related with other cardiovascular disorders such as arrhythmias. Flecainide administration for post-PFO-closure supraventricular arrhythmias can unmask a latent undiagnosed Brugada syndrome.
Versaci, F., Vizzari, G., Sergi, D., Andò, G., Trivisonno, A., Romeo, F. (2017). How often is patent foramen ovale an innocent bystander?. CLINICAL CASE REPORTS, 5(12), 1992-1994 [10.1002/ccr3.1237].
How often is patent foramen ovale an innocent bystander?
Versaci, Francesco
Writing – Review & Editing
;Sergi, DomenicoSupervision
;Romeo, FrancescoSupervision
2017-01-01
Abstract
Patent foramen ovale (PFO) is a risk factor for cryptogenetic stroke; its closure should be considered in selected patients. It is not always clear whether symptoms (presyncope, paresthesia) apparently due to paradoxical embolism are related with other cardiovascular disorders such as arrhythmias. Flecainide administration for post-PFO-closure supraventricular arrhythmias can unmask a latent undiagnosed Brugada syndrome.| File | Dimensione | Formato | |
|---|---|---|---|
|
Versaci 113_-_How_often_is_patent_foramen_ovale_an_innocent_bystander_-__Versaci__VIZZARI_-_Clinical_Case_Re.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
1.81 MB
Formato
Adobe PDF
|
1.81 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
